MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [RNA-seq_HDR]
Single-cell RNA-seq · human · 11 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 11 samples: 11 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcomaNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE274634_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1147318 and SRA study SRP525895. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 11 sample titles: 11 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8453997 RD_HDR_L122R_WT_RD-93_S14
- GSM8453998 RD_HDR_L122R_WT_RD-11_S13
- GSM8453999 RD_HDR_Ctrl_RD-60_S12
- GSM8454000 RD_HDR_L122R_WT_C11r1_A03_S03
- GSM8454001 RD_HDR_L122R_WT_C11r2_A09_S09
- GSM8454002 RD_HDR_L122R_WT_C93r1_A04_S04
- GSM8454003 RD_HDR_L122R_WT_C93r2_A10_S10
- GSM8454004 RD_HDR_WT_WT_C60r1_A02_S02
- GSM8454005 RD_HDR_WT_WT_C60r2_A08_S08
- GSM8454006 RD_HDR_WT_WT_C9r1_A01_S01
- GSM8454007 RD_HDR_WT_WT_C9r2_A07_S07
- GSE274638 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [scRNA-seq] 3 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces, rna-seq
- GSE274636 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [RNAseq_Ruch2oe] 15 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces
- GSE274635 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [RNAseq_Rdoe] 15 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces
- GSE274640 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma. 80 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces
- GSE274637 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [ChIP-seq] 32 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces
- GSE274639 MYOD1L122R induces cancer stem cell pathways to impart chemotherapy and radiation-resistance in aggressive rhabdomyosarcoma [scATAC-seq] 4 samples shares myod1l122r, radiation-resistance, rhabdomyosarcoma, chemotherapy, aggressive, induces
- GSE312030 Combined inhibition of HRAS and MEK induces tumor regression and restores myogenic differentiation in HRAS-mutant rhabdomyosarcoma 159 samples shares rhabdomyosarcoma, induces
- GSE224182 Genomic, transcriptomic, functional, and mechanistic characterization of rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusions (RNA-Seq) 57 samples shares rhabdomyosarcoma, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.